Author

Sareh Seyedi

Arizona State UniversityORCID 0009-0006-3263-2055Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Evolutionary Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:multiple species· 1 Approach:statistical model· 1

Frequent Co-Authors

Brigid V. TroaniD· 2 shared Carlo C. MaleyiD· 2 shared Alexander R.A. AndersoniD· 1 shared Amy M. BoddyiD· 1 shared Daniel K. SahaiD· 1 shared Darryl K. ShibataiD· 1 shared DW NorthfeltiD· 1 shared Elizabeth G. DukeiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersEvolutionary Biology

Brigid V. TroanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Evolutionary BiologybioRxivPreprintDec 11, 2025

Immune-cancer analyses across mammals reveal a potential trophic level and platelet-linked tradeoff between cancer and trauma mortality

Stefania E. Kapsetaki, Sareh Seyedi, Zachary Taylor Compton…·Amy M. Boddy

The paper analyzes immune-cancer tradeoffs across mammals, finding a negative correlation between cancer and trauma mortality, mediated by platelet size and trophic level.

1 citation

multiple speciesstatistical model

𝕏 PostBluesky

Cancer BiologyCancersPeer-reviewedJan 6, 2024

Testing Adaptive Therapy Protocols using Gemcitabine and Capecitabine on a Mouse Model of Endocrine-Resistant Breast Cancer

Sareh Seyedi, Ruthanne Teo, Luke Foster…·Carlo C. Maley

This study tests adaptive therapy protocols using gemcitabine and capecitabine on a mouse model of endocrine-resistant breast cancer, finding improved survival with adaptive strategies over high-dose combination therapy.

17 citationstop 5%

mouseexperimental assay

𝕏 PostBluesky